1. “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
   Astha Malik et al, 2021, Front. Oncol. CrossRef
2. Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma
   Rui Sun et al, 2021, Front. Oncol. CrossRef
3. An update on the role of complement in hepatocellular carcinoma
   Zhijie Xiao et al, 2022, Front. Immunol. CrossRef
4. The Complement System: A Potential Therapeutic Target in Liver Cancer
   Meng Yuan et al, 2022, Life CrossRef
5. Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
   Qinglin Ding et al, 2022, Front. Oncol. CrossRef
6. Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma
   Cuifang Han et al, 2023, Front. Oncol. CrossRef
7. Microarray data analysis of antileukemic action of Cinnamoylated benzaldehyde LQB-461 in Jurkat cell line
   Rachell R. C. Thimoteo et al, 2024, Mol Biol Rep CrossRef
8. The human factor H protein family – an update
   Noémi Sándor et al, 2024, Front. Immunol. CrossRef